Statin


THE ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) 142 West End Ave, Suite 28P New York, NY 10023 212-595-8974 ahrp@researchprotection.org September 4, 2002 Michael Carome, MD Associate Director for Regulatory Affairs Office for Human Research Protections The Tower Building 1101 Wootton Parkway, Suite 200 Rockville, Maryland 20852 Re: Acute Respiratory Distress […]

ARDSNet – AHRP Reply to OHRP Response


Guidant Didn’t Disclose a Flaw in Defibrillator for 3 Years_NYT / FDA Wrong on Crestor Safety Tue, 24 May 2005 The New York Times reports that the maker a a heart defirillator knew for 3 years about a malfunction and failed to inform physicians about It because the company “had […]

Guidant Didn't Disclose a Flaw in Defibrillator for 3 Years ...


Psychopharmacology in Turmoil: David Healy, MD Presentation Columbia + Debate Dr. Joseph Coyne, Ph.D Fri, 9 Dec 2005 Recent reports describing a determined effort to pathologize US infants and toddlers who are being declared to suffer from “severe mental disorders”–the latest, most aggressively marketed diagnosis for children is Bipolar disorder, […]

Psychopharmacology in Turmoil: David Healy, MD Presentation Columbia + Debate ...



Petition FDA to Investigate if SSRI Induced School Shootings Fri, 25 Mar 2005 The Minnesota shooting rampage by 16-year old Jeff Weise, prompted the parent organization, Ablechild.org, to petition the FDA to conduct “a full investigation into the possible SSRI induced school shootings.” “It took 15 years for the FDA […]

Petition FDA to Investigate if SSRI Induced School Shootings


More than 100 top regulatory officials represented industry as lobbyists, lawyers… – Denver Post Mon, 24 May 2004 To understand why government policies affecting healthcare, drug safety, food safety and the environment appear to promote industry interests at the expense of public safety and health, the Denver Post has investigated […]

More than 100 top regulatory officials represented industry as lobbyists, ...


Spitzer’s Lawsuit Will Shake Up the Drug Industry – Full Disclosure is the Goal Thu, 3 Jun 2004 New York State Attorney General, Eliot Spitzer’s lawsuit against GlaxoSmithKline challenges the pharmaceutical industry’s fraudulent marketing of drugs. Karen Barth Menzes, an attorney representing victims of antidepressant drug effects, told The (So. […]

Spitzer's Lawsuit Will Shake Up the Drug Industry – Full ...



Cholesterol Myths Debunked–Bad News for Statin Drug manufacturers Fri, 11 Jul 2003 The demise of hormone replacement therapy (HRT) is not the only case of medical fraud perpetrated by the medical establishment whose practitioners’ professional judgment and clinical practice is too often guided by the pharmaceutical industry. A major scientific […]

Cholesterol Myths Debunked–Bad News for Statin Drug manufacturers


China Daily A farming family’s recollection 2003-09-25 http://www1.chinadaily.com.cn/en/doc/2003-09/25/content_267233.htm Near-death experience after 55-year-old father of four inhales ‘fog-like’ spray China Features reporters XIONG LEI and WEN CHIHUA recently visited Zongyang County, in East China’s Anhui Province, to further dig into the allegations surrounding Harvard’s genetic studies in China. Their investigation was […]

China Daily investigation challenges US genetic experiments on poor farmers


Foster children AIDS Drug-Vaccine Experiments-Editorial – OpEd Sun, 22 May 2005 An editorial in the Toledo Blade, “Pediatric Shame,” expresses the moral indignation of the community upon learning that prestigious medical research Institutions nationwide exploited the vulnerability of children in foster care to test experimental AIDS drugs and vaccines: “in […]

Foster children AIDS Drug-Vaccine Experiments-Editorial – OpEd



AHRP Position Statement on Mental Health Screening – FDA Hearing Re: Drug Advertising Wed, 02 Nov 2005 FDA is holding public hearings (Nov 1, 2) Re:  Direct-to-Consumer Promotion of Medical Products at: National Transportation Safety Board Boardroom and Conference Center 429 L’Enfant Plaza, SW., Washington, DC 2 Time: 9:00 –5:00. […]

AHRP Position Statement on Mental Health Screening – FDA Hearing ...